Cargando…

MAT2B expression correlates with poor prognosis in triple-negative breast cancer

Background: In conjunction with the methionine adenosyltransferase 2A (MAT2A), MAT2B protein catalyses the formation of methyl donor S-adenosylmethionine to mediate cell metabolism, including proliferation and apoptosis. In this study, we investigated the functional and molecular mechanisms by which...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xu, Jin, Wu, Di, Wang, Siliang, Wang, Zhe
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2019
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6585407/ https://www.ncbi.nlm.nih.gov/pubmed/31354356 http://dx.doi.org/10.2147/CMAR.S200716

Ejemplares similares

Expression of RUNX1 Correlates with Poor Patient Prognosis in Triple Negative Breast Cancer
por: Ferrari, Nicola, et al.
Publicado: (2014)

High expression of UBD correlates with epirubicin resistance and indicates poor prognosis in triple-negative breast cancer
por: Han, Tao, et al.
Publicado: (2015)

The expressions of NEDD9 and E-cadherin correlate with metastasis and poor prognosis in triple-negative breast cancer patients
por: Li, Peng, et al.
Publicado: (2016)

Low KIBRA Expression Is Associated with Poor Prognosis in Patients with Triple-Negative Breast Cancer
por: Kim, So-Woon, et al.
Publicado: (2021)

Down-regulated FST expression is involved in the poor prognosis of triple-negative breast cancer
por: Liu, Sainan, et al.
Publicado: (2021)

Higher levels of TIMP-1 expression are associated with a poor prognosis in triple-negative breast cancer
por: Cheng, Guangcun, et al.
Publicado: (2016)

A CLDN1-Negative Phenotype Predicts Poor Prognosis in Triple-Negative Breast Cancer
por: Ma, Fei, et al.
Publicado: (2014)

TCOF1 upregulation in triple-negative breast cancer promotes stemness and tumour growth and correlates with poor prognosis
por: Hu, Jianyang, et al.
Publicado: (2021)

B7-H4 overexpression contributes to poor prognosis and drug-resistance in triple-negative breast cancer
por: Wang, Ling, et al.
Publicado: (2018)

High expression of microRNA-454 is associated with poor prognosis in triple-negative breast cancer
por: Cao, Zhi-Gang, et al.
Publicado: (2016)

circUSP42 Is Downregulated in Triple-Negative Breast Cancer and Associated With Poor Prognosis
por: Yu, Jinling, et al.
Publicado: (2020)

CD44(+)/CD24(−) phenotype predicts a poor prognosis in triple-negative breast cancer
por: Wang, Hui, et al.
Publicado: (2017)

High expression of CD47 in triple negative breast cancer is associated with epithelial-mesenchymal transition and poor prognosis
por: Yuan, Jingping, et al.
Publicado: (2019)

VISTA Expression on Immune Cells Correlates With Favorable Prognosis in Patients With Triple-Negative Breast Cancer
por: Cao, Xi, et al.
Publicado: (2021)

EGFR expression is associated with cytoplasmic staining of CXCR4 and predicts poor prognosis in triple-negative breast carcinomas
por: Li, Rong-Hui, et al.
Publicado: (2017)

CCNE1 amplification is associated with poor prognosis in patients with triple negative breast cancer
por: Zhao, Zi-Ming, et al.
Publicado: (2019)

Nestin expression associates with poor prognosis and triple negative phenotype in locally advanced (T4) breast cancer
por: Piras, F., et al.
Publicado: (2011)

Association of p53 expression with poor prognosis in patients with triple-negative breast invasive ductal carcinoma
por: Li, Jing-ping, et al.
Publicado: (2019)

Adipophilin expression is an independent marker for poor prognosis of patients with triple-negative breast cancer: An immunohistochemical study
por: Yoshikawa, Katsuhiro, et al.
Publicado: (2020)

T-cadherin is associated with prognosis in triple-negative breast cancer
por: Kong, De-Di, et al.
Publicado: (2017)

Aldehyde dehydrogenase 1 expression is correlated with poor prognosis in breast cancer
por: Yao, Juan, et al.
Publicado: (2017)

Triple-Negative Apocrine Breast Carcinoma Has Better Prognosis despite Poor Response to Neoadjuvant Chemotherapy
por: Hu, Taobo, et al.
Publicado: (2022)

High Survivin and Low Zinc Finger of the Cerebellum 1 Expression Indicates Poor Prognosis in Triple-negative Breast Carcinoma
por: Shi, Chun-Tao, et al.
Publicado: (2019)

Tumor-infiltrating B cells and T cells correlate with postoperative prognosis in triple-negative carcinoma of the breast
por: Kuroda, Hajime, et al.
Publicado: (2021)

Accumulation of p62 is associated with poor prognosis in patients with triple-negative breast cancer
por: Luo, Rong-Zhen, et al.
Publicado: (2013)

Ki67 as a predictor of poor prognosis in patients with triple-negative breast cancer
por: LI, HAITAO, et al.
Publicado: (2015)

Integrated bioinformatic analysis of potential biomarkers of poor prognosis in triple-negative breast cancer
por: Bissanum, Rassanee, et al.
Publicado: (2022)

CD24 Overexpression Is Associated with Poor Prognosis in Luminal A and Triple-Negative Breast Cancer
por: Kwon, Mi Jeong, et al.
Publicado: (2015)

Increased expression of MNK1b, the spliced isoform of MNK1, predicts poor prognosis and is associated with triple-negative breast cancer
por: Pinto-Díez, Celia, et al.
Publicado: (2018)

Upregulated expression of AT-rich interactive domain-containing protein 1B predicts poor prognosis in patients with triple-negative breast cancer
por: Cui, Yan, et al.
Publicado: (2019)

RPLP1 promotes tumor metastasis and is associated with a poor prognosis in triple-negative breast cancer patients
por: He, Zhixian, et al.
Publicado: (2018)

Low Expression of Circulating MicroRNA-34c is Associated with Poor Prognosis in Triple-Negative Breast Cancer
por: Zeng, Zhihao, et al.
Publicado: (2017)

Low HER2 expression is a predictor of poor prognosis in stage I triple-negative breast cancer
por: Sanomachi, Tomomi, et al.
Publicado: (2023)

ZGRF1 Is Associated with Poor Prognosis in Triple-Negative Breast Cancer and Promotes Cancer Stemness Based on Bioinformatics
por: Ge, Weiyu, et al.
Publicado: (2020)

Aurora-A Identifies Early Recurrence and Poor Prognosis and Promises a Potential Therapeutic Target in Triple Negative Breast Cancer
por: Xu, Jie, et al.
Publicado: (2013)

Poor prognosis of single hormone receptor- positive breast cancer: similar outcome as triple-negative breast cancer
por: Bae, Soo Youn, et al.
Publicado: (2015)

ID2 predicts poor prognosis in breast cancer, especially in triple-negative breast cancer, and inhibits E-cadherin expression
por: Li, Kai, et al.
Publicado: (2014)

Comparison of Clinicopathological Features and Prognosis in Triple-Negative and Non-Triple Negative Breast Cancer
por: Qiu, Jingdan, et al.
Publicado: (2016)

Insulin-like growth factor 2 receptor is a key immune-related gene that is correlated with a poor prognosis in patients with triple-negative breast cancer: A bioinformatics analysis
por: Zhong, Ying, et al.
Publicado: (2022)

Expression of Dickkopf-1 and Beta-Catenin Related to the Prognosis of Breast Cancer Patients with Triple Negative Phenotype
por: Xu, Wen-Huan, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_ht18ps7lt38aktr2lsfkk5n5k4